about
Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approachCoeliac diseaseThe function of tissue transglutaminase in celiac diseaseIncreased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in bloodEx vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms.Treatment of functional bowel disorders: is there room for antibiotics?Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating.The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms.Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.Rational Use of Antibiotics in the Treatment of Functional Bowel DisordersPrevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity.A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognosesPost-splenectomy and hyposplenic states.Celiac disease and alopecia areata: report of a new association.Antibodies to wheat high-molecular-weight glutenin subunits in patients with celiac disease.Genome search in celiac disease.Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.Visceral hypersensitivity and intolerance symptoms in lactose malabsorption.Clinical features of coeliac disease.World Gastroenterology Organisation global guidelines on celiac disease.Altered expression of type-1 and type-2 cannabinoid receptors in celiac diseaseHuman cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.PROgnosticating COeliac patieNts SUrvivaL: the PROCONSUL score.Immune reaction against the cytoskeleton in coeliac disease.Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease?Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's diseaseRelationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.A milligram of gluten a day keeps the mucosal recovery away: a case report.Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinants.Burden of Crohn's disease: economics and quality of life aspects in Italy.Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathyUsefulness of abdominal ultrasonography with studies of the intestinal loops in Turner syndrome patientsAbnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease.Role of the advanced glycation end products receptor in Crohn's disease inflammation.Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.Mortality in celiac disease.Recent advances in understanding Crohn's disease.
P50
Q26997909-EC1C97AD-8657-4EED-8832-992C6E072256Q28242747-9667A9B4-8EB6-4C34-B759-89E7F7826AF0Q28259501-F6FD93AF-8554-4E71-8509-22F04C32555BQ28307258-37FF76F5-87FE-49AB-807C-FBC45B2E8138Q30660529-51ACBF96-8C66-4F6A-8DE1-0BCB49900FD2Q33422135-E059D4A0-5818-432F-803D-CF54A9DE3047Q33434853-E3B92075-FE46-46AC-BA18-9C55DAE0539DQ33435908-A2574BC3-F343-4DC2-BA5E-CBF829B3111AQ33436314-D65AA7F1-01ED-4F40-A9F6-23E4F27B574DQ33448962-3AD559D3-BEE6-4F49-86B3-A82F86DC441FQ33468935-1C843220-32F9-4425-9463-E6866ED6BBCCQ33632204-E5FC5803-8B42-4E8A-8634-DB5260557EF9Q33740047-667A605B-CBE2-4473-B7B8-7AA9CC9B60BBQ34023073-3492B657-B34C-4226-B041-A92EA1193714Q34176573-C5A411B7-41CF-4F6B-A215-A97D3A00A551Q34295196-C273A937-D2F9-430A-A4FA-58BEF2A9F38FQ34344022-74B4B1E7-97F4-4B60-A76D-635601E70940Q34384694-2A1D59CC-646C-4945-AB60-79CF789AFC3AQ34463897-90F2C51A-482A-4023-9F7E-008882C53934Q34584407-6562AD63-9676-470E-87B2-0A63F83849A6Q34624660-D9FCB55B-F590-4BA1-A539-10C756CF3349Q34647268-1DDCB22B-45D0-4871-872A-4CDBB62AB319Q34689405-33364B98-0AAE-4890-B45D-ACE14A842780Q35069514-38BF943D-44B1-4095-BED4-8D36FA485B73Q35083320-BB05D989-8099-4D0D-BE98-39E54D7A169FQ35361713-A5204CFA-1DDE-4AEE-B50C-9351504ADF37Q35587804-D897E52D-74E9-4426-9660-8CCE4D700F79Q35596219-53DEDE1B-5CBE-4C52-8D7F-B52AF77CC6FBQ35640209-4D8E1571-37D5-4FBE-939A-8E72FFB34EA1Q35760432-5E48B746-5617-4F8E-80F3-548BD756C5DDQ35924741-A57065F5-179B-489C-92EB-62786A8AB543Q36135506-E9D1C461-5628-4903-B4BC-8D5CBA02653AQ36136475-364DE6B6-6700-4527-8B26-4873038F70E6Q36399050-08EE79F6-CEC2-490C-B84F-7951634B7D79Q37166998-167BA90D-9F65-4927-9FFD-4ABF754B2006Q37282566-013ED013-82B5-4352-8483-C3C130D205A0Q37378925-E2F1CEAE-AFE6-465F-AD8B-1A50BBE19F2BQ37432284-60DC5072-0455-48E9-8A83-3A4C4A905AA5Q37686062-630ECAA2-7834-4633-8004-E71D3FC84680Q37873392-5D291B83-F790-470E-9163-4135A2486FA1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gino R Corazza
@ast
Gino R Corazza
@en
Gino R Corazza
@es
Gino R Corazza
@nl
type
label
Gino R Corazza
@ast
Gino R Corazza
@en
Gino R Corazza
@es
Gino R Corazza
@nl
prefLabel
Gino R Corazza
@ast
Gino R Corazza
@en
Gino R Corazza
@es
Gino R Corazza
@nl
P106
P1153
35430063400
P31
P496
0000-0001-9532-0573